Actavis (ACT)

Add to Watchlists
Create an Alert
303.56 +2.24  +0.74% NYSE Mar 27, 8:00PM BATS Real time Currency in USD
View Full Chart
ACT Price Chart
View All Events

ACT Events

Date Type Description
03/17/2015 Misc Actavis Completes Allergan Acquisition
02/18/2015 08:30 EST Misc Actavis 2015 Investor Meeting
02/18/2015 Earnings Actavis PLC Fourth Quarter Earnings in 2014 Release
02/18/2015 Misc Actavis PLC Fourth Quarter Earnings Conference Call in 2014
11/05/2014 08:00 EDT Misc Actavis PLC Q3 2014 Earnings Call
11/05/2014 Earnings Actavis PLC Q3 2014 Earnings Results
10/06/2014 Misc Actavis to Acquire Durata Therapeutics, Inc.
08/05/2014 08:30 EDT Misc Q2 2014 Actavis PLC Earnings Conference Call
08/05/2014 Earnings Actavis PLC Q2 2014 Earnings Results
07/02/2014 Misc Actavis Announces Final Stockholder Merger Consideration Election Results in Connection With Forest Laboratories Acquisition
View All Performance Charts

ACT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Actavis is up 49.63% over the last year vs S&P 500 Total Return up 13.76%, Teva Pharmaceutical Indus up 29.36%, and Mylan up 26.86%.

Get Quote for

PDF Report for ACT

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACT Pro Report PDF

Portfolio Strategies Featuring ACT

Did Actavis make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACT Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Company Website:
  • IR Website:
  • HQ Country: Ireland
  • HQ State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: March 31, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Actavis PLC specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products.

ACT Excel Add-In Codes

  • Name: =YCI("ACT","name")
  • Description: =YCI("ACT","description")
  • Sector: =YCI("ACT","sector")
  • Industry: =YCI("ACT","industry")
  • Est. Current Fiscal Year End: =YCI("ACT","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.